Type 1 diabetes mellitus, Type 2 diabetes mellitus, Other diabetes mellitus, Prediabetes, Hypertension, Dyslipidemia, Obesity, Chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Have at least one of diabetes mellitus(type 1 diabetes mellitus, type 2 diabetes mellitus, other diabetes mellitus, prediabetes), hypertension, dyslipidemia, obesity, chronic kidney disease 2.HbA1c under 10% 3.More than 8 weeks before the trial registration, those without change in the usage and dosage of the therapeutic agent
Exclusion criteria
Exclusion criteria: 1.Patients of dementia 2.Other reasons leading the physician in charge to judge that the patient was unsuitable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset of dementia and mild cognitive impairment | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression of diabetes complications and other complications | — |
Countries
Japan
Contacts
Hyogo Medical University Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine